$1.92+0.11 (+6.08%)
Bluejay Diagnostics, Inc.
Bluejay Diagnostics, Inc. in the Healthcare sector is trading at $1.92. The stock is currently near its 52-week low of $1.65, remaining 58.6% below its 200-day moving average. Technical signals show neutral RSI of 60 and bullish MACD crossover, explaining why BJDX maintains its current current market pressure. The Whystock Score of 15/100 signals elevated caution as indicators diverge.
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Bluejay Diagnostics, Inc. operates as a medical diagnostics company. It offers Symphony technology platform which consists of an analyzer and single-use protein detection cartridges that are designed to provide measurements of key diagnostic biomarke...
US equity futures were flat ahead of Thursday's opening bell as traders digested earnings from Pepsi
Gibo Holdings Ltd. 239,477,124 0.049